{
  "report_rows": [
    {
      "kpi": "Non-GAAP diluted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.25 vs. cons $1.22",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total revenue (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.38B vs. cons $3.37B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA growth / margin (Q2 2026, value-creation cost savings flow-through)",
      "prediction": "BEAT",
      "answer": "pred ~+6% y/y adj. EBITDA growth vs. cons ~+5% y/y (implied mid-single-digit run-rate)",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 non-GAAP diluted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$5.23-$5.37 (reaffirmed) vs. cons $5.30 midpoint (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 total sales growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~3%-5% y/y (reaffirmed) vs. cons ~4% y/y (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Value-creation cost program run-rate savings commentary",
      "prediction": "UNCHANGED",
      "answer": "guide ~on track for $125M run-rate by YE2026 vs. cons expectation of ~$125M run-rate (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.0,
  "day5_path": "FADE",
  "day5_rationale": "Stock has rallied ~27% off May lows to just below its $89 average price target heading into the print, pricing in a beat-and-raise. A likely 'beat-but-reaffirm' outcome (Q2 EPS/revenue beat but FY guide simply reaffirmed rather than raised, as cost-savings ramp is still building toward H2) leaves implied H2 deceleration math intact; sell-side will need to trim out-quarter numbers to keep FY EPS within the unchanged $5.23-$5.37 band, and the leadership-transition overhang (COO/Chief Strategy Officer exits effective Oct 30) adds execution-risk discounting, driving a fade after the initial print rather than follow-through.",
  "day5_confidence": "MEDIUM"
}